Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus Nephritis

Authors:
  • BSBianca M. Simonetti
    Bianca M. Simonetti
  • GPGabriella Pecci
    Gabriella Pecci
  • GMGiorgio Mavrikakis
    Giorgio Mavrikakis
  • SFSandro Feriozzi
    Sandro Feriozzi
  • GCGiulio A. Cinotti
    Giulio A. Cinotti
  • PPPaola Patrignani
    Paola Patrignani
  • GCGiovanni Ciabattoni
    Giovanni Ciabattoni
  • CPCarlo Patrono
    Carlo Patrono

Abstract
To test the hypothesis that the vasoconstrictor thromboxane A2 may affect renal hemodynamics in lupus nephritis, we examined the short-term effects of a selective thromboxane-receptor antagonist, BM 13,177, and of low-dose aspirin.

This publication has 16 references indexed in Scilit: